Metabolomic-based investigation of Yinlan alleviating hyperlipidemia by inhibiting blood stasis and phlegm turbidity through the PXR-CYP3A4-ABCB1-FXR pathway

Yinlan lipid regulatory capsule (YL) is a composite traditional Chinese medicine (TCM) new drug to alleviate hyperlipidemia, while its therapeutic mechanism in vivo was not clarified with nontargeted metabolomics investigation. An animal model was established in rats fed a high-fat diet, and their body weights, body mass index (BMI) and blood cholesterol levels were measured. Serum, liver and kidney tissue samples were also extracted for PXR-CYP3A4-ABCB1-FXR signaling pathway research using PCR and UHPLC–MS. The obtained plasma samples were analyzed by UHPLC-Q-TOF-MS metabolomic investigation, which revealed PXR-CYP3A4-related metabolites and changes induced by YL. Finally, the key metabolites were chosen as index components, and their levels in the serum, liver, small intestine and bile were used for simultaneous UHPLC–MS-MS determination. The results indicated that YL was effective in rebalancing blood TG and TC levels (compared to controls). With respect to the PXR-CYP3A4-ABCB1 pathway, as a result of YL’s effect, gene expression or activity of the two targets decreased significantly in both the liver and kidney. The same trend was observed in the serum samples mentioned above. Metabolomics screening and data revealed that 44 metabolites can be regarded as biomarkers related to hyperlipidemia, fatty acids synthesis, and body energy consumption, as well as synthesis, transportation and exertion of cholesterol. YL’s treatment focused on 26 of them, primarily bile acids, indicating that the antihyperlipidemic effect of this drug lies in its inhibitory activity of cholesterol metabolism. Subsequent analysis of those in vivo components revealed that significant increases (compared to the model group) occurred in the blood, liver, small intestine and bile in groups that received medium and high doses of YL (while the low dose was relatively unchanged). Those target components exhibit a close relationship with PXR and/or CYP3A4. The use of YL repressed PXR expression and subsequently decreased CYP3A4 activity. As a result, synthesis of related bile acids increased, while cholesterol levels decreased, consequently leading to the attenuation of hyperlipidemia. This study comprehensively investigated the antihyperlipidemia mechanism of YL based on its repression of PXR-CYP3A4 activity and related metabolite yield, establishing an accurate method for evaluating the therapeutic effect of YL.     

杂多蓝的研究 I. 具有Dawson结构的钼砷杂多蓝的制备及性质

本文详细地研究了具有Dawson结构的钼砷杂多酸(H6As2Mo18O62)的两电子、四电子、六电子还原杂多蓝的制备条件, 离析出了它们的钾盐、铵盐及四丁基胺盐。找到了合适的电解电位。通过电位滴定、极谱、电子光谱、红外光谱、X射线粉末衍射和光电子能谱的研究, 确证了所希望得到的产物。研究表明, 杂多蓝的结构与还原前相比未发生明显变化。水溶液稳定性的研究指出, 杂多蓝要比还原前的杂多阴离子稳定, 存在的PH范围加宽, 指认了可见-红外区出现的谱带。     

Hydroxyapatite gels and nanocrystals prepared through a sol-gel process

We have investigated the effect of the Ca/P molar ratio on the structural and morphological properties of hydroxyapatite (HA) gels and nanocrystals. The sol-gel process was carried out in aqueous, and alternatively in alcoholic medium (50% water-50% ethanol), at 37°C. Gel samples were obtained by drying the sols at 37°C or at 80°C, whereas powder samples were obtained by filtering the sols. Heat treatment at temperatures as low as 300°C is enough to obtain pure HA from the gels with a Ca/P molar ratio of 1.00 and 1.67. At variance, heat treatment of the gels with a Ca/P of 2.55 always produces secondary phases. The degree of crystallinity of HA increases with the Ca/P molar ratio of the sols, and it is slightly affected by the presence of ethanol in the precipitation medium. Filtering of the sols provides powders constituted of nanocrystalline HA that exhibit degree of crystallinity, crystal morphology and thermal stability closely related to the sols composition.     

N'-(4,5,6-三取代嘧啶-2-基)-2-噻吩磺酰脲的合成

2-氨基-4,5,6-三取代嘧啶和2-噻吩磺酰异氰酸酯发生亲核加成反应, 生成13种含4,5,6-三取代嘧啶环的噻吩磺酰脲,产率高, 它们均为未见文献报道的新化合物.它们的分子结构经^1H NMR, IR和元素分析等测试而得到确证, 并对其生物活性进行了初步研究.     

化学复合镀Ni-P-PTFE镀层的组成分析

近年来化学复合镀技术在工业中应用日益广泛 ,本文运用ＳＥＭ、ＡＥＳ和ＸＰＳ等手段对用化学复合镀制得的Ｎｉ Ｐ ＰＴＦＥ镀层的结构和组分进行了分析 ,并就其耐腐蚀性能与前期得到的Ｎｉ Ｓｎ Ｐ[1 ] 、Ｃｕ Ｓｎ Ｐ[2 ] 、Ｎｉ Ｐ ＣｅＯ2 [3] 、Ｎｉ Ｐ ＳｉＯ2 [4] 镀层进行了比较 ,结果表明 :含量一定的ＰＴＦＥ(聚四氟乙烯 )的共存增强镀层的耐腐蚀性及镀层表面的润滑性。1　实验部分1 1　仪器日产Ｄ/ＭＡＸⅢＡ型Ｘ 射线衍射仪 ,铜靶 ,管压 2 5ｋＶ ,电流 1 0ｍＡ。国产ＪＪＣ 1型润滑湿角测量仪。美国ＰＥＲＫＩＮ ＥＬＭＥＲＰ…     

N-烯基硝酮分子内环加成反应区域选择性的理论研究 3:N-4-甲基-4-戊烯基硝酮分子内环加成反应的区域选择性

N-4-甲基-4-戊烯基硝酮分子内环加成反应可以生成氧桥型(Pa)和碳桥型(Pb)两种产物, 其实验产率比约为8:1。而在N-4位未取代的情况下, Pa与Pb的实验产率比约为1:2。可见N-4-甲基使得区域选择性发生了很大的变化。本文用AM1 MO方法和过渡状态理论研究了N-4-甲基-4-戊烯基硝酮分子内环加成反应的机理。计算了两个平行反应(a, b)的速率常数的比值, 得到与实验吻合的结果。计算表明, N-4-甲基取代后, a, b两反应的活化熵的相对变化是区域选择性改变的主要因素, 活化焓的相对变化只是一个次要因素。     

四氮杂大环四烯镍(Ⅱ)配合物[Ni(TIM)]X催化BrO 氧化双有机底物的振荡反应

本文报道了四氮杂大环四烯镍(Ⅱ)配人事物[Ni(TIM]X[TIM为2,3,9,10-1,4,8,11-甲氮杂环十四-1,3,8,10-四烯;X=(ClO~4)~2,ZnCl~4,(SCN)~2]催化BrO CH~2(CO~H)~2-(CO~2H~2)-H~2SO~4体系的新型振荡化学反应.对该振荡反应体系进行了多方面的研究,并提出了简要的机理.     

Spectroscopic and Electrochemical Characterization of Cytochrome P450st‐DDAB Films on a Plastic‐Formed Carbon Electrode

We have studied the characterization of thermophilic cytochrome P450 (P450st)‐didodecyldimethylammonium bromide (DDAB) films by using UV‐vis absorption, resonance Raman spectroscopy, and electrochemical methods. The observed Raman spectrum indicated near‐native conformation of the heme iron in DDAB film on the surface of a glass slide, while on the surface of a plastic‐formed carbon (PFC) electrode, the conformation of P450st‐DDAB was very similar to that of heme‐DDAB film, suggesting the release of heme from P450st in DDAB films on PFC electrodes. When NaBr was added as salt to the casting solution, the result of Raman spectrum indicated near‐native conformation of P450st in DDAB film even on the PFC electrode, but no redox potential of P450st which has near native structure was observed. This study suggests the essential experimental conditions when working with heme protein‐DDAB films as, in some cases, heme iron from proteins is released on the surface of the electrode.     

番红花化学成分研究 III. 番红花花粉中的番红花新苷甲和乙的结构

从番红花(crocus sativus L.)花粉中分到两个新苷, 命名为番红花新苷甲(1)和乙(2)。经理化性质和对它们的IR、UV、^1HNMR和MS数据的分析, 鉴定1为异鼠李素-4'-O-α-L-鼠李吡喃(1→2)β-D-葡萄吡喃糖苷, 2为β-对羟基苯基-乙醇-α-O-α-L-鼠李吡喃糖(1→2)-β-D-葡萄吡喃糖苷。     

1,1'-(六甲基三硅撑)双环戊二烯基二(对氯苯氧基)钛的合成及晶体结构

以1,3-二氯六甲基三硅烷相继与环戊二烯基钠、正丁基锂和四氯化钛作用合成了1,1'-(六甲基三硅撑)双环戊二烯基二氯化钛(1),1在氨基钠的存在下与对氯苯酚作用制得题目化合物(2)。通过元素分析、^1HNMR和MS鉴定了1与2的结构,并对2进行X射线结构分析确证了其结构。2的晶体属单斜晶系的P21/c空间群。晶胞参数:a=1.0746(3),b=2.4865(7),c=1.2568(2)nm; β=113.42(2)°;V=3.08137nm^3;Z=4,D0=1.305g·cm^-3。化合物中三个硅原子的桥链发生明显扭曲。通过氧原子中心原钛与苯环发生共轭,使整个分子形成共轭体系。